{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:26:03Z","timestamp":1758043563407,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019447","name":"Applied Basic Research Project of Shanxi Province, China","doi-asserted-by":"publisher","award":["202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210"],"award-info":[{"award-number":["202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210","202303021211210"]}],"id":[{"id":"10.13039\/501100019447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province","award":["20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029"],"award-info":[{"award-number":["20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029","20210029"]}]},{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","award":["2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072"],"award-info":[{"award-number":["2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072","2024072"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139"],"award-info":[{"award-number":["81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139","81400139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00277-025-06545-1","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T01:22:28Z","timestamp":1754875348000},"page":"4081-4091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["t(8;21)AML patients with RUNX1e6::RUNX1T19a splice variant have poor prognosis"],"prefix":"10.1007","volume":"104","author":[{"given":"Yuying","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwen","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-8655","authenticated-orcid":false,"given":"Yanhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"9","key":"6545_CR1","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1182\/blood-2006-09-045583","volume":"109","author":"A Boyapati","year":"2007","unstructured":"Boyapati A, Yan M, Peterson LF, Biggs JR, Le Beau MM, Zhang DE (2007) A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy. Blood 109(9):3963\u20133971","journal-title":"Blood"},{"key":"6545_CR2","first-page":"104631","volume":"2011","author":"H Reikvam","year":"2011","unstructured":"Reikvam H, Hatfield KJ, Kittang AO, Hovland R, Bruserud O (2011) Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. J Biomed Biotechnol 2011:104631","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"6545_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1182\/bloodadvances.2019000168","volume":"4","author":"S Al-Harbi","year":"2020","unstructured":"Al-Harbi S, Aljurf M, Mohty M, Almohareb F, Ahmed S (2020) An update on the molecular pathogenesis and potential therapeutic targeting of AML wiRUNX1T1. Blood adv 4(1):229\u2013238","journal-title":"Blood adv"},{"key":"6545_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-981-10-3233-2_12","volume":"962","author":"KH Metzeler","year":"2017","unstructured":"Metzeler KH, Bloomfield CD (2017) Clinical relevance of RUNX1 and CBFB alterations in acute myeloid leukemia and other hematological disorders. Adv Exp Med Biol 962:175\u2013199","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"6545_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41375-019-0697-0","volume":"34","author":"S Opatz","year":"2020","unstructured":"Opatz S, Bamopoulos SA, Metzeler KH, Herold T, Ksienzyk B, Braundl K et al (2020) The clinical mutatome of core binding factor leukemia. Leukemia 34(6):1553\u20131562","journal-title":"Leukemia"},{"issue":"7","key":"6545_CR6","first-page":"698","volume":"53","author":"A Numata","year":"2012","unstructured":"Numata A, Fujimaki K, Aoshima T, Onizuka M, Hagihara M, Miyazaki K et al (2012) Retrospective analysis of treatment outcomes in 70 patients with t(8;21) acute myeloid leukemia. Rinsho Ketsueki 53(7):698\u2013704","journal-title":"Rinsho Ketsueki"},{"issue":"13","key":"6545_CR7","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia group B (CALGB 8461). Blood 100(13):4325\u20134336","journal-title":"Blood"},{"issue":"1","key":"6545_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-1119(98)00141-3","volume":"212","author":"JK Wolford","year":"1998","unstructured":"Wolford JK, Prochazka M (1998) Structure and expression of the human MTG8\/ETO gene. Gene 212(1):103\u2013109","journal-title":"Gene"},{"issue":"49","key":"6545_CR9","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1073\/pnas.0406702101","volume":"101","author":"M Yan","year":"2004","unstructured":"Yan M, Burel SA, Peterson LF, Kanbe E, Iwasaki H, Boyapati A et al (2004) Deletion of an AML1-ETO C-terminal NcoR\/SMRT-interacting region strongly induces leukemia development. Proc Natl Acad Sci USA 101(49):17186\u201317191","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"6545_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/gcc.20165","volume":"43","author":"T Kozu","year":"2005","unstructured":"Kozu T, Fukuyama T, Yamami T, Akagi K, Kaneko Y (2005) MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21). Genes Chromosomes Cancer 43(1):45\u201353","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"6545_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/leu.2013.53","volume":"27","author":"L Solari","year":"2013","unstructured":"Solari L, Bauer T, Dicker F, Haferlach C, Griesshammer M, Schnittger S et al (2013) A novel recurrent AML1-ETO fusion: tight in vivo association with BCR-ABL1. Leukemia 27(6):1397\u20131400","journal-title":"Leukemia"},{"issue":"8","key":"6545_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm1443","volume":"12","author":"M Yan","year":"2006","unstructured":"Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y et al (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 12(8):945\u2013949","journal-title":"Nat Med"},{"issue":"9","key":"6545_CR13","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/leu.2009.104","volume":"23","author":"B Jiao","year":"2009","unstructured":"Jiao B, Wu CF, Liang Y, Chen HM, Xiong SM, Chen B et al (2009) AML1-ETO9a is correlated with C-KIT overexpression\/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2. Leukemia 23(9):1598\u20131604","journal-title":"Leukemia"},{"issue":"2","key":"6545_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41375-019-0551-4","volume":"34","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Schwarz P, Giaimo BD, Bedzhov I, Corbacioglu A, Weber D et al (2020) Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML). Leukemia 34(2):630\u20134","journal-title":"Leukemia"},{"issue":"1","key":"6545_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41375-023-02063-z","volume":"38","author":"M Yan","year":"2024","unstructured":"Yan M, Liu M, Davis AG, Stoner SA, Zhang DE (2024) Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation. Leukemia 38(1):31\u201344","journal-title":"Leukemia"},{"issue":"38","key":"6545_CR16","first-page":"5665","volume":"40","author":"K Rejeski","year":"2021","unstructured":"Rejeski K, Duque-Afonso J, Lubbert M (2021) AML1\/ETO and its function as a regulator of gene transcription via. Epigenetic Mech Oncogene 40(38):5665\u20135676","journal-title":"Epigenetic Mech Oncogene"},{"issue":"5","key":"6545_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1101\/gad.11.5.640","volume":"11","author":"L Bruhn","year":"1997","unstructured":"Bruhn L, Munnerlyn A, Grosschedl R (1997) ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev 11(5):640\u2013653","journal-title":"Genes Dev"},{"issue":"24","key":"6545_CR18","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","volume":"23","author":"LF Peterson","year":"2004","unstructured":"Peterson LF, Zhang DE (2004) The 8;21 translocation in leukemogenesis. Oncogene 23(24):4255\u20134262","journal-title":"Oncogene"},{"issue":"5688","key":"6545_CR19","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1126\/science.1097937","volume":"305","author":"J Zhang","year":"2004","unstructured":"Zhang J, Kalkum M, Yamamura S, Chait BT, Roeder RG (2004) E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305(5688):1286\u20131289","journal-title":"Science"},{"issue":"15","key":"6545_CR20","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1182\/blood-2008-06-161307","volume":"113","author":"S Park","year":"2009","unstructured":"Park S, Chen W, Cierpicki T, Tonelli M, Cai X, Speck NA et al (2009) Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity. Blood 113(15):3558\u20133567","journal-title":"Blood"},{"issue":"27","key":"6545_CR21","doi-asserted-by":"publisher","first-page":"10242","DOI":"10.1073\/pnas.0603463103","volume":"103","author":"MJ Plevin","year":"2006","unstructured":"Plevin MJ, Zhang J, Guo C, Roeder RG, Ikura M (2006) The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain. Proc Natl Acad Sci USA 103(27):10242\u201310247","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"6545_CR22","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1038\/s41598-022-17913-6","volume":"12","author":"M Gopalswamy","year":"2022","unstructured":"Gopalswamy M, Kroeger T, Bickel D, Frieg B, Akter S, Schott-Verdugo S et al (2022) Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1\/ETO tetramerization with anti-leukemic effects. Sci Rep 12(1):14158","journal-title":"Sci Rep"},{"issue":"5","key":"6545_CR23","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1158\/0008-5472.CAN-06-3360","volume":"67","author":"C Wichmann","year":"2007","unstructured":"Wichmann C, Chen L, Heinrich M, Baus D, Pfitzner E, Zornig M et al (2007) Targeting the oligomerization domain of ETO interferes with RUNX1\/ETO oncogenic activity in t(8;21)-positive leukemic cells. Cancer Res 67(5):2280\u20132289","journal-title":"Cancer Res"},{"issue":"4","key":"6545_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/leu.2009.288","volume":"24","author":"D Mannari","year":"2010","unstructured":"Mannari D, Gascoyne D, Dunne J, Chaplin T, Young B (2010) A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia. Leukemia 24(4):891\u2013894","journal-title":"Leukemia"},{"issue":"4","key":"6545_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1182\/blood-2008-04-153742","volume":"113","author":"M Yan","year":"2009","unstructured":"Yan M, Ahn EY, Hiebert SW, Zhang DE (2009) RUNX1\/AML1 DNA-binding domain and ETO\/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood 113(4):883\u2013886","journal-title":"Blood"},{"issue":"2","key":"6545_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055481","volume":"8","author":"XN Gao","year":"2013","unstructured":"Gao XN, Lin J, Ning QY, Gao L, Yao YS, Zhou JH et al (2013) A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. PLoS One 8(2):e55481","journal-title":"PLoS One"},{"issue":"12","key":"6545_CR27","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/leu.2013.197","volume":"27","author":"MC Lo","year":"2013","unstructured":"Lo MC, Peterson LF, Yan M, Cong X, Hickman JH, Dekelver RC et al (2013) JAK inhibitors suppress t(8;21) fusion protein-induced leukemia. Leukemia 27(12):2272\u20132279","journal-title":"Leukemia"},{"issue":"127","key":"6545_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003562","volume":"4","author":"T Zhen","year":"2012","unstructured":"Zhen T, Wu CF, Liu P, Wu HY, Zhou GB, Lu Y et al (2012) Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. Sci Transl Med 4(127):127ra38","journal-title":"Sci Transl Med"},{"issue":"1","key":"6545_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00964-9","volume":"12","author":"JM Salmon","year":"2020","unstructured":"Salmon JM, Bots M, Vidacs E, Stanley KL, Atadja P, Zuber J et al (2020) Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia. Clin Epigenetics 12(1):178","journal-title":"Clin Epigenetics"},{"issue":"7","key":"6545_CR30","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2011-12-395335","volume":"120","author":"MC Lo","year":"2012","unstructured":"Lo MC, Peterson LF, Yan M, Cong X, Jin F, Shia WJ et al (2012) Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML. Blood 120(7):1473\u20131484","journal-title":"Blood"},{"issue":"16","key":"6545_CR31","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1128\/MCB.21.16.5577-5590.2001","volume":"21","author":"SA Burel","year":"2001","unstructured":"Burel SA, Harakawa N, Zhou L, Pabst T, Tenen DG et al (2001) Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Mol Cell Biol 21(16):5577\u20135590","journal-title":"Mol Cell Biol"},{"key":"6545_CR32","doi-asserted-by":"publisher","first-page":"992714","DOI":"10.3389\/fcell.2022.992714","volume":"10","author":"YF Zhang","year":"2022","unstructured":"Zhang YF, Wang XL, Xu CH, Liu N, Zhang L, Zhang YM et al (2022) A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation. Front Cell Dev Biol 10:992714","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"6545_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2006.10.010","volume":"251","author":"KE Elagib","year":"2007","unstructured":"Elagib KE, Goldfarb AN (2007) Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation. Cancer Lett 251(2):179\u2013186","journal-title":"Cancer Lett"},{"issue":"8","key":"6545_CR34","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1172\/JCI24225","volume":"115","author":"C Schessl","year":"2005","unstructured":"Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM et al (2005) The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 115(8):2159\u20132168","journal-title":"J Clin Invest"},{"issue":"8","key":"6545_CR35","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2005-04-1656","volume":"107","author":"S Nishida","year":"2006","unstructured":"Nishida S, Hosen N, Shirakata T, Kanato K, Yanagihara M, Nakatsuka S et al (2006) AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Blood 107(8):3303\u20133312","journal-title":"Blood"},{"issue":"6","key":"6545_CR36","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1073\/pnas.1019625108","volume":"108","author":"YY Wang","year":"2011","unstructured":"Wang YY, Zhao LJ, Wu CF, Liu P, Shi L, Liang Y et al (2011) C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci USA 108(6):2450\u20132455","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"6545_CR37","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1073\/pnas.1531730100","volume":"100","author":"JL Grisolano","year":"2003","unstructured":"Grisolano JL, O\u2019Neal J, Cain J, Tomasson MH (2003) An activated receptor tyrosine kinase, Tel\/Pdgfbetar, cooperates with AML1\/ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci U S A 100(16):9506\u20139511","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06545-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06545-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06545-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:48:50Z","timestamp":1757663330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06545-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6545"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06545-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All samples collected in this study were approved by the Ethics Committee of the Second Hospital of Shanxi Medical University, approval number: 2023086.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}